Heather H. Cheng, MD, PhD, discusses the role of genetic testing in prostate cancer as it continues to evolve in this space. This year, the 2019 NCCN guidelines focused more on genetic testing in select patients with prostate cancer.
Heather H. Cheng, MD, PhD
Advertisement
Articles by Heather H. Cheng, MD, PhD
Advertisement
Latest Updated Articles
Genetic Testing Plays Larger Role in Treatment of Prostate CancerPublished: December 18th 2019 | Updated:
Advertisement
Advertisement
Trending on Targeted Oncology - Immunotherapy, Biomarkers, and Cancer Pathways
1
FDA Grants Traditional Approval to Pirtobrutinib in CLL/SLL
2
Durable Responses With Novel Cell Therapy TARA-002 in BCG-Naive NMIBC
3
JANX007 Shows Promising Efficacy, Safety in Phase 1 Trial Update
4
LP-184 Demonstrates Favorable Efficacy and Safety in Advanced Solid Tumors
5
